Did You Get Real Informed Consent for Your Psychiatric Medication?
Informed consent for psychiatric medication means you were told the real risks, including how hard the drug can be to stop, before you ever took the first dose. Most people never get that conversation. They are handed a prescription, told the drug is safe and corrective, and sent home without a word about dependence or withdrawal.
If that was your experience, you are not imagining the gap. Genuine informed consent for psychiatric medication is a legal and ethical standard, and the evidence shows it is routinely skipped. This post explains what that standard actually requires, why it matters most for stopping, and how our free Informed Consent Generator helps you document the conversation you should have had.
What does informed consent for psychiatric medication actually require?
Informed consent requires three things: that you are told the benefits, the risks, and the reasonable alternatives, in language you understand, with enough time to decide. It is not a signature on a form. It is a conversation that leaves you genuinely able to weigh the choice.
For psychiatric drugs, the risk half of that conversation is where it breaks down. The benefits get explained. The alternatives sometimes do. But the specific risk of physical dependence and a difficult withdrawal is the part most often left out entirely.
The UK's National Institute for Health and Care Excellence makes this explicit. Its guideline on shared decision making (NG197) says patients should be active partners in decisions, given balanced information on benefits and harms, including what happens when a medicine is stopped. That last clause is the one that gets ignored.
Bottom line: real informed consent means you knew, before starting, that the drug could be hard to come off. If no one told you that, your consent was incomplete.
Why withdrawal risk is the missing piece
The single most under-disclosed fact about antidepressants and other psychiatric drugs is how common and how severe withdrawal can be. For years patients were told discontinuation was mild and brief. The evidence says otherwise.
A 2019 systematic review by Davies and Read, published in Addictive Behaviors, found that around half of people who stop antidepressants experience withdrawal, and that a large share describe it as severe. This directly contradicted the older guidance that framed withdrawal as minor.
That same year, a study by Horowitz and Taylor in The Lancet Psychiatry showed why standard fast tapers fail and argued for gradual, hyperbolic tapering instead. The science had shifted, but the consent conversation at the point of prescribing mostly had not.
Some drugs are harder than others. Short-acting antidepressants like Effexor and Paxil are notorious for sharp withdrawal. None of that difficulty is a secret to researchers, yet few patients hear about it when they start.
Bottom line: withdrawal is common, sometimes severe, and well documented. A consent process that hides it is not informed consent.
Rushed consent versus genuine informed consent
The difference between a rushed handoff and real informed consent is concrete. The table below shows what each one covers.
| What should be discussed | Rushed prescription | Genuine informed consent | ||---| | Expected benefits | Yes | Yes | | Common side effects | Sometimes | Yes | | Risk of physical dependence | Rarely | Yes | | How hard the drug is to stop | Almost never | Yes | | That withdrawal can last months | Almost never | Yes | | Reasonable alternatives | Rarely | Yes | | A plan for stopping later | Almost never | Yes | | Your right to change your mind | Rarely | Yes |
Most people recognize the left column. The point is not to assign blame to one prescriber. It is that the system normalized a thin version of consent, and you are entitled to the full one.
The Royal College of Psychiatrists now acknowledges this directly. Its position statement on stopping antidepressants recognizes that withdrawal can be severe and prolonged for some people, and that patients deserve clear information and support.
Bottom line: if your consent only covered the left column, you were short-changed, and you can close the gap now.
How our Informed Consent Generator helps
The Informed Consent Generator builds a clear, personalized document of the risks and questions that should be part of your medication decision, so you can have the real conversation with your prescriber. It turns a vague sense of unease into specific, answerable questions.
You enter the medication and your situation, and the tool produces a structured summary: the dependence and withdrawal risks for that drug class, the alternatives worth discussing, and the questions to ask before starting or while planning to stop. You bring it to your appointment.
This matters for two moments. The first is starting a new drug, where you want the full picture before you commit. The second, and more common for our community, is when you are already on a medication and deciding how to come off it safely.
It is education, not medical advice, and it does not replace your prescriber. What it does is rebalance the conversation, so you walk in with the same information your clinician has.
Bottom line: the generator gives you a written, specific basis for the consent conversation, whether you are starting a drug or planning to stop one.
What to do if your consent was incomplete
If you realize now that you were never told about withdrawal, you have several concrete next steps, and none of them involve stopping your medication abruptly. Abrupt discontinuation is exactly the wrong move.
Start by documenting the gap. Use the Informed Consent Generator to lay out what should have been discussed for your specific drug. This gives you a clear agenda for your next appointment rather than a vague grievance.
If your current prescriber dismisses withdrawal or refuses to support a slow taper, you may need someone who understands deprescribing. Our find a deprescribing provider directory lists clinicians who take withdrawal seriously and will work with you on a gradual plan.
To understand the principles yourself, the deprescribing education section explains how and why tapering works, in plain language. And once you begin, tracking your taper day by day gives you and your provider real data on how you are responding, instead of guesswork.
Bottom line: incomplete consent is fixable. Document it, find a provider who gets it, learn the principles, and track your progress.
What real informed consent looks like in practice
In practice, genuine informed consent is an ongoing conversation, not a one-time event at the pharmacy counter. It continues as your needs change, especially when you decide the drug has done its job and you want to stop.
A good consent conversation about stopping covers the realistic timeline, the fact that slower is usually safer, and the reassurance that you can pause or hold at any point if symptoms get rough. It treats you as the decision-maker, with your clinician as the expert guide.
This is the model that deprescribing organizations promote. The Canadian network at deprescribing.org and the Maudsley Deprescribing Guidelines both frame stopping as a planned, shared, reversible process, not a failure or an afterthought.
Patient advocacy has driven much of this change. Outlets like Mad in America have spent years documenting the consent gap and pushing the field to take withdrawal seriously. The standard is catching up to what patients always knew.
Bottom line: real consent is continuous and shared, and it explicitly includes a safe, reversible plan for stopping.
Frequently asked questions
Is informed consent legally required for psychiatric medication?
Yes. Informed consent is a legal and ethical requirement for prescribing, including psychiatric drugs. It requires disclosure of material risks, including dependence and withdrawal, in terms you can understand. A signature alone does not satisfy it if the risks were never genuinely explained.
My doctor never mentioned withdrawal. Did they do something wrong?
The conversation you got reflects a system-wide pattern, not necessarily one bad clinician. For years official guidance understated withdrawal, so many prescribers were never trained to discuss it. What matters now is getting the full information and a proper plan going forward.
Can I sue for lack of informed consent?
This article is educational and not legal advice. Standards and remedies vary by country and jurisdiction. If you believe you were harmed by inadequate consent, consult a qualified lawyer in your area. For most people, the more useful step is documenting the gap and getting better care now.
What should I ask before starting a psychiatric drug?
Ask how the drug can be stopped, how long withdrawal typically lasts, how common dependence is, what the alternatives are, and what the plan will be if you want to come off later. Our Informed Consent Generator produces these questions tailored to your specific medication.
Does using the consent tool mean I should stop my medication?
No. The tool informs your decision; it does not make it, and it never tells you to stop. Many people use it precisely to plan a safe, gradual taper with their prescriber. Never stop a psychiatric drug abruptly.
The bottom line
Informed consent for psychiatric medication is supposed to mean you knew the real risks, including how hard the drug could be to stop, before you started. The evidence shows that conversation is routinely skipped, and the part most often missing is withdrawal. That is not your fault, and it is fixable.
Whether you are starting a medication or planning to come off one, you deserve the full picture. Use the Informed Consent Generator to build it, and join the conversation at taper.community with people who have walked the same path.
Medical disclaimer: This article is for educational purposes only and is not medical or legal advice. Do not start, stop, or change any psychiatric medication without the guidance of a qualified healthcare professional who knows your history. Stopping psychiatric drugs abruptly can be dangerous.